the invention relates to a new mammalian s - type lectin , termed galectin - 8 , and to galectin - 8 - like proteins , to fragments thereof , to dna molecules coding therefor and to pharmaceutical compositions comprising said proteins . galectin - 8 , a widely expressed protein of 35 kda is shown to be implicated in regulation of cell growth , particularly in inhibition of cell proliferation .